References
- Tang GW, Russell RM. 13-cis-retinoic acid is an endogenous compound in human serum. J Lipid Res 1990; 31:175–182.
- Lowenstein EB, Lowenstein EJ. Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero. Clin Dermatol 2011; 29:652–661.
- Rosa FW. Teratogenicity of isotretinoin (letter). Lancet 1983; 2: 513.
- Rosa FW, Wilk AL, Kelsey FO. Teratogen update: vitamin A congeners. Teratology 1986; 33:355–364.
- Nau H. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid. J Am Acad Dermatol 2001; 45:S183–S187.
- Mitchell AA, Van Bennekom CM, Louik C. A pregnancy-prevention program in women of childbearing age receiving isotretinoin. N Engl J Med 1995; 333:101–106.
- Bérard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br J Clin Pharmacol 2007; 63:196–205.
- Garcia-Bournissen F, Tsur L, Goldstein LH, Staroselsky A, Avner M, Asrar F, . Fetal exposure to isotretinoin - an international problem. Reprod Toxicol 2008; 25:124–128.
- Autret-Leca E, Kreft-Jais C, Elefant E, Cissoko H, Darrouzain F, Grimaldi-Bensouda L, . Isotretinoin exposure during pregnancy: assessment of spontaneous reports in France. Drug Saf 2010; 33:659–665.
- Schaefer C, Meister R, Weber-Schoendorfer C. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy. Arch Gynecol Obstet 2010; 281:221–227.
- Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, . Retinoic acid embryopathy. N Engl J Med 1985; 313: 837–841.
- Dai WS, LaBraico JM, Stern RS. Epidemiology of isotretinoin exposure during pregnancy. J Am Acad Dermatol 1992; 26: 599–606.
- United Kingdom Teratology Information Service (UKTIS). Use of isotretinoin in pregnancy. 2008. Available at http://www.uktis.org./index.html. Accessed August 7, 2012.
- Grønhøj LF, Jakobsen P, Grønhøj LC, Heidenheim M, Held E, Nielsen-Kudsk F. The metabolism and pharmacokinetics of isotretinoin in patients with acne and rosacea are not influenced by ethanol. Br J Dermatol 2009; 161:664–670.
- Wyss R, Bucheli F. Determination of endogenous levels of 13- cis-retinoic acid (isotretinoin), all-trans-retinoic acid (tretinoin) and their 4-oxo metabolites in human and animal plasma by high-performance liquid chromatography with automated column switching and ultraviolet detection. J Chromatogr B Biomed Sci Appl 1997; 700:31–47.
- Abroms L, Maibach E, Lyon-Daniel K, Feldman SR. What is the best approach to reducing birth defects associated with isotretinoin?PLoS Med 2006; 3:e483.
- Han JY, Nava-Ocampo AA, Koren G. Unintended pregnancies and exposure to potential human teratogens. Birth Defects Res A Clin Mol Teratol 2005; 73:245–248.
- Lee SW, Han JY, Choi JS, Chung JH, Kim MY, Yang JH, . Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study. Reprod Toxicol 2009; 27:196–198.
- Lee HJ, Han JY, Yook JH, Choi JS, Ahn HK, Kim MY, . A prospective cohort study of pregnancy outcomes of women inadvertently exposed to methylephedrine in the 1st trimester of pregnancy. J Obstet Gynaecol 2010; 30:563–566.
- Lee JE, Han JY, Choi JS, Ahn HK, Lee SW, Kim MH, . Pregnancy outcome after exposure to the probiotic Lactobacillus in early pregnancy. J Obstet Gynaecol 2012; 32:227–229.
- Borghi A, Mantovani L, Minghetti S, Giari S, Virgili A, Bettoli V. Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission. J Eur Acad Dermatol Venereol 2011; 25:1094–1098.
- Helbig A, Kaasen A, Malt UF, Haugen G. Psychological distress after recent detection of fetal malformation: short-term effect on second-trimester uteroplacental and fetoplacental circulation. BJOG 2011; 118:1653–1657.